Westlake Village biotech company ImmunoCellular Therapeutics announced Tuesday that it has applied for continued public quoting on the over-the-counter market to comply with amended Rule 15c2-11 under the Securities and Exchange Act. ...

Join our Membership to get the full story.


Are you a current Member? Sign In